Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study-Reference-Cited by-同舟云学术

Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study

Published:2021-04 Issue:2 Volume:6 Page:100073
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Borelli B.,Fontana E.,Giordano M.,Antoniotti C.,Lonardi S.,Bergamo F.,Pietrantonio F.,Morano F.,Tamburini E.,Boccaccino A.,Santini D.,Zucchelli G.,Pella N.,Maiello E.,Passardi A.,Zaniboni A.,Ugolini C.,Fontanini G.,Falcone A.,Nyamundanda G.,Sadanandam A.,Cremolini C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Heterogeneity in colorectal cancer: a challenge for personalized medicine?;Molinari;Int J Mol Sci,2018

2. Cancer genome landscapes;Vogelstein;Science,2013

3. A colorectal cancer classification system that associates cellular phenotype and responses to therapy;Sadanandam;Nat Med,2013

4. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions;De Sousa E Melo;Nat Med,2013

5. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines;Schlicker;BMC Med Genomics,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors;British Journal of Cancer;2024-09-04

2. Expression characteristics of tumors as prognostic and predictive markers for resectable and locally advanced colorectal cancer;Russian Journal of Biotherapy;2024-06-26

3. Molecular testing in colorectal cancer;Diagnostic Molecular Pathology;2024

4. Experimental Murine Models for Colorectal Cancer Research;Cancers;2023-04-30

5. Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review);Oncology Letters;2023-04-18